As of Jun 27, 2018 UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) Sellers Declined Their Shorts By 40.16%

June 27, 2018 - By Gwen Gough

UCB SA (OTCMKTS:UCBJF) Corporate Logo

UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) had a decrease of its shares shorted by 40.16%. It was issued in June by FINRA the 123,800 shares shorted on UCBJF. The down change of 40.16% from 206,900 shares was reported. With Average volume 200, UCBJF’s former position will take 619 days to restore. Float short on UCB S A ORDINARY SHARES BELGIUM is 0.11%.

At traded at $78.18 lastly.It’s since June 27, 2017 and is 0.00% down. UCBJF underperformed by 12.57% the S&P 500.

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system.The company has $14.94 billion market cap. The Company’s core products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, Crohn??s disease, psoriatic arthritis, and rheumatoid arthritis; Keppra, Vimpat, and Briviact for epilepsy; and Neupro for Parkinson??s disease and restless legs syndrome.The P/E ratio is 16.86. The firm also offers Zyrtec and Xyzal for allergy; Venlafaxine ER for depressive and anxiety disorders; Nootropil for cognitive disorders; and Xyrem for narcolepsy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: